terms-but not in the last weeks or months. Prognostication, difficult enough in cancer, is almost impossible until the very end in non-malignant disease; 2 therefore most care will have to take place outside separate-site specialist palliative care units and, at the very least, in close partnership with the referring specialists. The present unknowns, as Addington-Hall reiterates, should not discourage us from getting involved. We cannot opt out, but neither should we wade in with 'our' model; rather, we should publish the experience we have gained in treating patients with non-malignant disease (even if we lack data from randomized controlled trials) and learn with and from our colleagues in other areas of clinical medicine.
A difficulty for palliative care is that it functions in parallel universes. Management of Advanced Disease is excellent on organizational issues, but I would have liked more comment on the propagation of palliative medicine from one setting to another. Can there be another specialty that works and trains in such a variety of settings-the world of the acute hospital or primary care trust, where in the UK National Health Service palliative medicine lacks waiting-list initiatives or well-defined targets to encourage or extract funding in a competitive 'market place'; and the world of the hospice, where clinicians negotiate with medical and lay people who have generally worked very hard to provide funding, spurred on by the experience of a personal or family tragedy? In the hospice setting, money is not the issue (provided the stock market is favourable and fundraisers are energetic) but funding is harder to obtain for less immediately and overtly beneficial projects, such as education. The effort of working with groups of people who 'know' what an institution needs and are impatient with humdrum employment practices 3 can be deeply wearying and may contribute to individual burnout. Construction of a chapter on these issues would be difficult-but perhaps worth a try in the next edition.
Management of Advanced Disease fills a niche unoccupied by the large reference texts such as the Oxford Textbook of Palliative Medicine or the shorter symptom control guides such as OUP's Oxford Core Text or Blackwell Scientific's Handbook of Palliative Care. The particular importance of the book lies in its general section and the reviews of non-malignant disease and organizational issues. It is for the commentaries on these broader themes of palliative care, in a work that also offers portable advice on symptom control, that the editors and contributors deserve special congratulations. I shall turn to it frequently in both clinical and managerial practice.
Sara Booth
Palliative Care Service, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK Allyson Pollock, well known for her trenchant and often brave criticisms of government policies about the National Health Service, has assembled an impressively well documented account of the steady encroachment of market principles and practices into the provision of a public service-a process that began in the 1980s and has gathered pace ever since. The result is a withering critique not only of the shameless transfer of cost-effective public services to the profit-hungry private sector but also of the betrayal of the central values of the NHS-integrated planning to meet defined needs, the provision of adequate services at all stages of people's lives, equality of access to care, uniformity of standards and professional trust.
Pollock's central message is simple but devastating: for the past fifteen years Conservative and Labour governments alike have encouraged the boundaries between publicly and privately provided healthcare in Britain to become increasingly blurred, allowing commercial companies to infiltrate the NHS. Alien values have been introduced, costly managerial technologies have proliferated, and a great deal of public money has seeped into the profit margins of the commercial sector. It has happened in the hospitals, in primary care and in long-term care and little of it has happened by accident or default. Indeed, there has been (in Pollock's view) a virtual collusion between government and commerce to allow the private sector to take a growing share of taxpayers' money in return for a lesser quantity and poorer quality of service provision. By way of documenting this assertion, names are named, confidences are shared, and a certain amount of gossip is leaked. One hopes that the publisher's lawyers have done a good job with their proof-reading.
Yet Pollock's book is far removed from the sensationalism that often pervades crusading journalism. It is a passionate book, certainly, but the passion is largely subterranean, only occasionally breaking through the measured and scholarly arguments in the shape of acerbic comments about the sale of hospital land to create new golf courses, the horse-trading in clinical services that takes place over comfortable dinners in London clubs and the activities of the subsequently disgraced MP, Jonathan Aitken, in skewing the provision of hospital services in East Kent. Such occasional barbs apart, the tone of the book is sober, the evidence is carefully documented, and the arguments are compelling. We find ourselves hopping with indignation at the bare-faced treachery of our political masters, wanting to call them instantly to account for selling out the NHS. How dare successive Secretaries of State from the 1980s onwards play fast and loose with the most popular public service that has ever been created in the free world? Why have they been allowed to get away with it? Why is Parliament so remiss in failing to see what is happening?
Allyson Pollock is to be applauded for allowing us to peer deeply into this particular Pandora's box and she is to be admired for her courage in doing so. As she explains in the book, she has suffered personally at the hands of those for whom political spin is more important than evidence or truth. And yet, for all that this is a challenging and disturbing book, it does not wholly convince. The arguments flow unremittingly one way. Pollock sometimes sounds like an unreconstructed Bevanite, yearning to turn the clock back to a time when everything in the NHS garden was pristine, promising and public. Half-hidden like a watermark on every page of her book is the neo-Orwellian mantra 'private bad, public good'. In the innocent and optimistic days of the 1950s and 1960s, services were planned in a rational and coordinated manner, general practitioners provided 24-hour care for entire families, hospitals were built with public capital, and values such as public service, political integrity and social justice were taken seriously. Yet Pollock gives scant attention either to the reasons why the old-style NHS was ultimately seen to have failed or to the possible benefits of the new mixed economy of health. The final judgment on the Private Finance Initiative, foundation hospitals and primary care trusts might yet go her way, but we need to hear the case for the defence before making up our minds.
It is here, perhaps, that Allyson Pollock's campaign begins to falter, for the clock cannot be turned back and the errors of the past (if such they were) cannot be undone. At the very end of the book she observes that 'if the NHS had been funded since its inception on the scale of other EU health systems, the public discontent that the privatisers were able to exploit could have been averted'. That may well be true; but the NHS wasn't funded on the scale of most other healthcare systems and public discontent hasn't been averted. The NHS has to move on from the position in which it actually finds itself, not some imagined position that we would ideally like it to be in. Pollock's prescription for the future, in the final sentence of her book, is rousing: 'What is now required is not reform but revolution-a quiet, collective revolution of the sort that brought the NHS into being in the first place'. Many will say 'amen' to this clarion call. Yet where is the momentum for the 'quiet revolution' to come from? Who is there waiting in the wings to become a latter-day Bevan? How can governments be beaten when the game is played by the rules that they themselves have set? On these questions Allyson Pollock is silent.
John Butler
Emeritus Professor, University of Kent, UK
The Oxford Companion to the Mind
Editor: Richard L. Gregory pp. 1024 Price £40 ISBN 0-19-866224-6 (h/b).
Oxford: Oxford University Press Books
There is a way of looking at the world which holds that the human mind and its contents are all that there is. The second edition of Richard Gregory's lovely book does justice to the greatness of its subject and to its renowned predecessor. If Gilgamesh is the first book of the human heart, the Oxford Companion to the Mind is on a short-list of those dedicated to the heart's more calculating runningmate. It makes good the dust-jacket's boast that this is, indeed, an edition for the new century. The book's compact and sober exterior belies a breadth and exuberance as astonishing as the paradoxes it celebrates. In the course of its 959 pages we are taken on a journey from the abacus to zombies, with stops along the way at such out-of-the-way places as the mysteries of the colour brown, the winning of chess endgames (and the blunders of Kasparov), why doubles are bad news, the legal validity of psychopaths, what the Buddha had to say about visual perception, the manners of conversing with kings (or carving a joint of meat), the history of the jigsaw puzzle, why Adzell the Wodenite was intrinsically good, and the scientific status of levitation and ghosts (whether Pepper's ghost, or more homely apparitions). It would be almost true to say that all of human (mental) life is here, from the weightiest meditations on our past and our future, as individuals and as a species, to such ticklish subjects as, well, tickling. Nor does the Companion confine itself to mind as it is instantiated in human brains: the operation of other minds in our fellow creatures, and the possibility of future minds in our own digital creations, are themes treated at length.
The Companion's honour roll of 316 authors (129 new to the present edition) have contributed universally readable, frequently entertaining, and sometimes historic pieces ranging in scope from definitions and brief vignettes to substantial essays. It is a measure of the eclecticism of this enterprise that the list of contributors includes, besides neuroscientists young and old, Beryl Bainbridge, Roger Penrose, and Patrick Moore. Alongside the exotic and the esoteric, the more traditional subject matter of the core brain sciences of
